Our sector specialties include: Consumer; Healthcare; Media; Power & Energy Transition; and Technology. Guggenheim Equity Research analysts average 18 years of Wall Street and industry experience, bringing our clients rich perspectives and deep domain expertise.
Rigorous primary research is central to our approach. Innovation and disruption are constants in the sectors we cover and on-the-ground work keeps our team at the leading edge of trend changes for the benefit of our clients. Our signature research products uncover these findings and include:
The Consumer team covers automotive, e-commerce, hardline and softline retail, and restaurants.
The Healthcare team covers biotechnology, biopharmaceuticals, diagnostics and life sciences tools, and healthcare services.
The Power & Energy Transition team covers energy & industrial technology, power, and utilities.
For access to our research offerings and products, please contact your Guggenheim Securities Sales representative or email GSInfo@guggenheimpartners.com.
Already Registered? View the content library on the research portal (login required).
I&I Spotlight Series – Treg-based Therapies
Senior Managing Directors Whitney Wolfe and Yatin Suneja partake in a Q&A session regarding the future of the Treg-Therapies.
Highlights From the Second Guggenheim Targeted Protein Day
Senior Managing Director Michael Schmidt discusses the key topics from the event.
| Date | Sector | Location | Conference Name |
|---|---|---|---|
| 3/31 | Healthcare | Virtual | Private Biopharma Company Virtual 1x1 Day |
| 6/23-6/26 | Healthcare | Boston | BioFrontier Bus Tour |
Guggenheim Thanks Participants and Attendees of Biotech Summit
Guggenheim Securities hosted its 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐎𝐮𝐭𝐥𝐨𝐨𝐤: 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐒𝐮𝐦𝐦𝐢𝐭, on February 11-12, in New York. The conference brought together executives from 81 leading public biopharma companies and 600 attendees, and featured more than 1,650 client meetings. The conference created meaningful knowledge exchanges, strategic networking, and dialogue around current trends and future outlooks within biotech innovation.
Michael Morris Discusses Future of NFL Media Rights on Podcast
Media & Internet Equity Research Analyst Michael Morris recently joined Puck's "The Varsity" podcast with host John Ourand to discuss his outlook for the National Football League (NFL)'s next media rights negotiations, including why he expects that there will be more game content made available to major streamers in comparison to the current NFL media rights agreement.
John DiFucci Outlines Software Landscape Amid AI Revolution
Software Equity Research Analyst JOHN DIFUCCI recently joined Yahoo Finance’s Julie Hyman to analyze the performance of the Agentforce platform and share his market outlook for the software industry. DiFucci also highlighted the types of software companies that he believes are most equipped to thrive as the artificial intelligence revolution progresses.
